Innovation Pharmaceuticals Inc (IPIX)

[mdphd2008]

Nice CTIX news today:

I guess that partially explains why there was limited progression over past few months to move forward on brilacidin for eye, ear, and foot indications.

Honestly, I did not fully realize that
Brilacidin was not stable at room temperature and that was a temporary limiting factor moving the platform forward.

Although, today's news is unlikely to significantly move share price in the very short term, but nevertheless, it's good to know further overall progress and continued advancement of pipeline remains a very strong priority.